The reduction in Royce & Associates' stake from a prior larger position suggests gradual portfolio rebalancing rather than a conviction change. Monitor for any further reductions or a shift to a 13D filing, which would signal activist intent.
Price Chart
Executive Summary
Royce & Associates LP filed an amended Schedule 13G disclosing a 0.848% passive stake (700,750 shares) in NN Inc. as of September 30, 2026. The filing confirms a reduction from a prior larger position, as the firm remains a passive investment manager with no intent to influence control.
Key Financial Metrics
Key Facts
- Royce & Associates LP reported beneficial ownership of 700,750 shares of NN Inc. common stock as of September 30, 2026.
- The stake represents 0.848% of shares outstanding.
- The filing is an amendment to Schedule 13G, confirming passive investor status under Rule 13d-1(d).
- Royce & Associates LP is an indirect majority-owned subsidiary of Franklin Templeton, Inc. (formerly Franklin Resources, Inc.).
- The firm disclaims pecuniary interest and beneficial ownership of the securities reported.
Financial Impact
Stake of 700,750 shares valued at approximately $2.8M based on market cap of $329M and 0.848% ownership.
Risk Factors
- Further selling by Royce & Associates could pressure the stock.
- The passive filing status limits the likelihood of activist engagement from this holder.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000906304-26-000203 |
| Document: 0000906304-26-000203-index.html | 0000906304-26-000203 |
| Document: 0000906304-26-000203.txt | 0000906304-26-000203 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 29, 2026 1d ago | SC 13G/A | $3.96 | awaiting T+60 | awaiting T+60 | $3.93 (−0.76%) |
Oct 28, 2026 2d ago | 8-K | No price | awaiting T+60 | awaiting T+60 | No price |
Oct 28, 2026 2d ago | Press Release | $3.96 | awaiting T+60 | awaiting T+60 | $3.93 (−0.76%) |
Oct 26, 2026 4d ago | EFFECT | $3.36 | awaiting T+60 | awaiting T+60 | $3.93 (+16.96%) |
Oct 15, 2026 15d ago | Press Release | $3.41 | awaiting T+60 | awaiting T+60 | $3.93 (+15.25%) |
Oct 13, 2026 17d ago | S-3 | $3.46 | awaiting T+60 | awaiting T+60 | $3.93 (−13.75%) |
Oct 8, 2026 22d ago | 8-K | $4.01 | awaiting T+60 | awaiting T+60 | $3.93 (−2.00%) |
Oct 5, 2026 25d ago | 8-K | $4.04 | awaiting T+60 | awaiting T+60 | $3.93 (+2.72%) |
Sep 22, 2026 5w ago | Press Release | $3.86 | awaiting T+60 | awaiting T+60 | $3.93 (+1.81%) |
Sep 22, 2026 5w ago | 8-K | $3.86 | awaiting T+60 | awaiting T+60 | $3.93 (+1.81%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers